Table 3 Medication classes which were previously used by the participants for their preventive treatments
From: Real-life experiences with galcanezumab and predictors for treatment response in Turkey
Medication class | %, (n) |
|---|---|
Antidepressant drugs | 55.9, 266 |
Antiepileptic drugs | 51.9, 247 |
Onabotulinum-toxinA | 37.0, 176 |
Beta blockers | 34.2, 163 |
Calcium channel blockers | 29.2, 139 |
Nerve blocks | 27.1, 129 |
Acupuncture | 20.0, 95 |
Neural treatment | 9.9, 47 |
Other mAbs imported from abroad | 1.5, 7 |
Migraine surgery | 1.5, 7 |